| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.1 | 0.09 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.077 | 0.09 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |